Analyst Ratings for Forte Biosciences Inc. (FBRX)
FBRX Rating Summary
FBRX Price Target Summary
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$76.60 (-0.1%)
* Over Last 12-Mos
Rating Score: 4.5 / 10
Percentile Rank: 46%
Avg. $ Target:
$76.60 (-0.1%)
* Over Last 12-Mos
Rating Score: 4.5 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/28/2026 | Barclays | Etzer Darout | Downgrade | Equalweight (Overweight) |
77.00 (74.00) |
54.78 (76.65) |
39.92% | Details |
| 7/27/2026 | Brookline Capital Markets | Kumaraguru Raja | Downgrade | Hold (Buy) |
77.00 (N/A) |
54.78 (76.65) |
39.92% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


